NASH: A global health problem (Q44967242)

7 December 2017

title

NASH: A global health problem (English)

1 reference

7 December 2017

0 references

Arun J. Sanyal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21711426

5 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21711426

5 December 2024

publication date

1 July 2011

1 reference

7 December 2017

July 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21711426

full work available at URL

5 December 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111/j.1872-034X.2011.00824.x

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1872-034X.2011.00824.x

5 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

5 December 2024

1 reference

7 December 2017

volume

41

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

670-674

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

The spectrum of liver disease in the general population: lesson from the Dionysos study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Selection and outcome of living donors for adult to adult right lobe transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Nonalcoholic fatty liver disease in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Prevalence and correlates of diabetes in South asian indians in the United States: findings from the metabolic syndrome and atherosclerosis in South asians living in america study and the multi-ethnic study of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Hepatitis C virus and nonalcoholic Fatty liver disease: similar risk factors for necroinflammation, fibrosis, and cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Population-based risk factors and resource utilization for HCC: US perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Pathology of nonalcoholic fatty liver disease

5 December 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation

5 December 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Metabolic syndrome from the view point of public health: with special reference to nonalcoholic fatty liver disease

5 December 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Prevalence of and risk factors for hepatic steatosis in Northern Italy

5 December 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome

5 December 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2011.00824.X

5 December 2024

Identifiers

1 reference

7 December 2017

1 reference